Medtronic Stock (NYSE:MDT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$87.77

52W Range

$68.84 - $91.49

50D Avg

$86.58

200D Avg

$83.83

Market Cap

$113.19B

Avg Vol (3M)

$6.46M

Beta

0.85

Div Yield

$2.80 (3.15%)

MDT Company Profile


Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

IE

Employees

95,000

IPO Date

May 02, 1973

Website

MDT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceApr 24Apr 23Apr 22
Diabetes Group$2.49B$2.26B-
Cardiac and Vascular Group$11.83B$11.57B-
Medical Surgical$8.42B$8.43B-
Neuroscience Group$9.41B$8.96B-
Neuroscience Portfolio-$8.96B$5.75B
Medical Surgical Portfolio-$8.43B$3.86B
Diabetes Operating Unit-$2.26B-
Cardiovascular-$11.57B$5.54B

Fiscal year ends in Apr 24 | Currency in USD

MDT Financial Summary


Apr 24Apr 23Apr 22
Revenue$32.36B$31.23B$31.69B
Operating Income$5.14B$5.49B$5.75B
Net Income$3.68B$3.76B$5.04B
EBITDA$5.14B$9.04B$8.93B
Basic EPS$2.77$2.83$3.75
Diluted EPS$2.76$2.82$3.73

Fiscal year ends in Apr 24 | Currency in USD

Latest Earnings Call Transcripts


Q1 25Aug 20, 24 | 11:36 AM
Q4 24May 23, 24 | 12:05 PM
Q3 24Feb 20, 24 | 12:58 PM

Peer Comparison


TickerCompany
ZBHZimmer Biomet Holdings, Inc.
ABTAbbott Laboratories
PODDInsulet Corporation
SYKStryker Corporation
EWEdwards Lifesciences Corporation
DXCMDexCom, Inc.
TNDMTandem Diabetes Care, Inc.
ALGNAlign Technology, Inc.